Lorence Kim

American businessperson, doctor and board member.¹

Companies

CencoraBoard member Oct 1, 2022 to now⁶
Revolution Medicines (United States)Board member Jul 13, 2022 to now⁷
TD CowenBoard member Feb 17, 2022 to Mar 1, 2023⁸
ModernaChief financial officer Dec 7, 2018 to Jun 4, 2020⁹
Seres Therapeutics, Inc.Board member Jun 25, 2015 to Jun 14, 2019¹⁰

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Cencora COR4,153 shares¹¹$1.4M at $340.08Mar 5, 2026
Revolution Medicines (United States) RVMD1,191 shares¹²$216.9K at $182.09Sep 10, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Sep 8, 2026Sold 371 shares at $212.27 of Revolution Medicines (United States)¹²
Sep 8, 2026Sold 3,844 shares at $211.36 of Revolution Medicines (United States)¹²
Sep 8, 2026Sold 4,730 shares at $210.50 of Revolution Medicines (United States)¹²
Sep 8, 2026Sold 2,853 shares at $209.56 of Revolution Medicines (United States)¹²
Sep 8, 2026Sold 3,587 shares at $208.55 of Revolution Medicines (United States)¹²
Sep 8, 2026Sold 999 shares at $207.33 of Revolution Medicines (United States)¹²
Sep 8, 2026Sold 706 shares at $206.60 of Revolution Medicines (United States)¹²
Aug 31, 2026Sold 625 shares at $206.15 of Revolution Medicines (United States)¹³
Aug 31, 2026Sold 2,128 shares at $205.19 of Revolution Medicines (United States)¹³
Aug 31, 2026Sold 7,271 shares at $204.35 of Revolution Medicines (United States)¹³
Aug 31, 2026Sold 26,160 shares at $203.55 of Revolution Medicines (United States)¹³
Aug 31, 2026Sold 12,919 shares at $202.48 of Revolution Medicines (United States)¹³
Aug 31, 2026Sold 6,597 shares at $201.47 of Revolution Medicines (United States)¹³
Aug 31, 2026Sold 300 shares at $200.56 of Revolution Medicines (United States)¹³
Jun 18, 2026Granted 1,191 shares of Revolution Medicines (United States)¹⁴
Mar 5, 2026Granted 557 shares at $359.28 of Cencora¹¹
Jun 26, 2025Granted 3,142 shares of Revolution Medicines (United States)¹⁵
Mar 6, 2025Granted 789 shares of Cencora¹⁶
Jun 20, 2024Granted 4,248 shares of Revolution Medicines (United States)¹⁷
Jun 20, 2024Granted 4,800 shares of Revolution Medicines (United States)¹⁸
Mar 12, 2024Granted 843 shares of Cencora¹⁹
Jun 8, 2023Granted 5,200 shares of Revolution Medicines (United States)²⁰
Mar 9, 2023Granted 1,334 shares of Cencora²¹
Mar 1, 2023Returned to company 8,236 shares at $39.00 of CIK 1466538²²
Mar 1, 2023Returned to company 30,000 shares at $39.00 of CIK 1466538²²

Early life and education

1991 to 1995Harvard University Bachelor of Arts^{2 3}
1995 to 2000Perelman School of Medicine at the University of Pennsylvania Doctor of Medicine^{2 3}
1998 to 2000The Wharton School Master of Business Administration^{2 3}

Career

Since 2022Board member, Cencora⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
WikidataLorence Kim on Wikidata
2
WikidataLorence Kim: education, on Wikidata
3
Wikidataeducation, as reported
4
WikidataLorence Kim: Board member, Cencora, on Wikidata
5
WikidataLorence Kim: LinkedIn, on Wikidata
6
Wikidata and SEC EDGARCencora, Board member
7
SEC EDGARRevolution Medicines (United States), Board member
8
SEC EDGARTD Cowen, Board member
9
SEC EDGARModerna, Chief financial officer
10
SEC EDGARSeres Therapeutics, Inc., Board member
11
SEC EDGARCencora shares after the filing of Mar 5, 2026
12
SEC EDGARRevolution Medicines (United States) shares after the filing of Sep 10, 2026
13
SEC EDGARForm 4 filed Sep 2, 2026
14
SEC EDGARForm 4 filed Jun 23, 2026
15
SEC EDGARForm 4 filed Jun 30, 2025
16
SEC EDGARForm 4 filed Mar 10, 2025
17
SEC EDGARForm 4 filed Jun 28, 2024
18
SEC EDGARForm 4 filed Jun 24, 2024
19
SEC EDGARForm 4 filed Mar 13, 2024
20
SEC EDGARForm 4 filed Jun 12, 2023
21
SEC EDGARForm 4 filed Mar 13, 2023
22
SEC EDGARForm 4 filed Mar 1, 2023